Over the last few years, there has been increasing pressure on the U.S. health care system: this includes issues related to ...

The end of the line is looming for Oxurion, after a clinical trial of its last pipeline drug for diabetic macular oedema (DME) failed to meet its primary endpoint. With its cash reserves dwindling ...

The seal is aimed at identifying products manufactured domestically and supporting efforts to strengthen the U.S. medical supply chain, according to an April 3 press release shared with Becker’s.

Experts discuss how cancer treatment and survivorship can be made more equitable and affordable through advocacy, outreach, and effective communication tools. Beyond Cancer: Caring for Young ...

Apr. 4, 2025 — Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a ...

Lobby groups like AdvaMed and the American Hospital Association have so far failed to get medical devices and critical supplies carved out from the Trump administration’s tariffs. Atrial ...

A study from researchers at the University of Colorado Anschutz Medical Campus reveals that nearly one in five U.S. adults have used multiple drugs in the past year, showing that substance use is ...

Dr Neil Skolnik explains the ACP's new clinical guideline for the prevention of episodic migraines — and how it differs from the recent AHS position statement.

BURNABY, B.C. – The government of Saskatchewan has expanded public coverage for continuous glucose monitoring (CGM) systems. The expansion, which now provides full coverage for CGMs for young adults ...